ALX Oncology Holdings, Inc. (ALXO)
1.56
+0.09
(+6.12%)
USD |
NASDAQ |
Dec 10, 16:00
1.56
0.00 (0.00%)
After-Hours: 16:42
ALX Oncology Holdings Total Liabilities (Quarterly): 37.92M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Prelude Therapeutics, Inc. | 36.22M |
| Werewolf Therapeutics, Inc. | 50.01M |
| Erasca, Inc. | 72.52M |
| Immuneering Corp. | 13.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.72M |
| Shareholders Equity (Quarterly) | 44.80M |
| Debt to Equity Ratio | 0.3484 |
| Current Ratio | 2.399 |
| Net Debt Paydown Yield | 0.38% |